The Agency for the Development of the Pharmaceutical Industry of Uzbekistan held a meeting with representatives of Partex AI on August 26, 2026. The goal of the negotiations was to discuss the integration of artificial intelligence technologies and digital solutions into the country's pharmaceutical and biomedical sectors.
During the meeting in Tashkent, representatives of the agency and company executives focused on several key areas. These include the digitalization of the pharmaceutical industry, the use of AI to optimize drug development processes, and the implementation of digital tools in daily production activities.
Areas of AI Application in Pharmaceuticals
Discussions covered the application of artificial intelligence in pharmaceuticals and biotechnology. Special emphasis was placed on expanding scientific research, enhancing data analysis capabilities, and introducing advanced technologies into production cycles.
Agency representatives outlined the existing opportunities for implementing digital technologies and AI-based solutions in Uzbekistan's pharmaceutical sector, presenting information on current innovative projects in this field. At the conclusion of the talks, both parties agreed to maintain continuous dialogue regarding the implementation of AI and digital solutions and plan further experience exchange and joint project development.